Dataset Information


Differential regulation of SGK1 by progesterone activates AP-1/NDRG1 genomic axis in PR-positive and negative breast cancer cells

ABSTRACT: Pre-operative progesterone intervention has been shown to confer a survival benefit to breast cancer patients independent of their progesterone receptor (PR) status, raising a question about how progesterone affects the outcome of PR-negative cells. Here, we identify up-regulation of a Serum- and glucocorticoid-regulated kinase gene, SGK1 and an N-Myc Downstream Regulated Gene 1, NDRG1, along with down-regulation of miR-29a and miR-101-1 targeting 3’UTR region of SGK1, to differential extents in a PR dependent manner in breast cancer cells. We further demonstrate a novel dual-phase transcriptional and post-transcriptional regulation of SGK1 in response to progesterone leading to up-regulation of a tumor metastasis suppressor gene, NDRG1, mediated by a set of AP-1 network genes. The NDRG1 further inactivates a set of kinases impeding the invasion and migration of breast cancer cells. In summary, we propose a model for the mode of action of progesterone in breast cancer deciphering the molecular basis of a randomized clinical trial studying the effect of progesterone in breast cancer with a potential to improve the prognosis of breast cancer patients for receiving pre-operative progesterone treatment.

ORGANISM(S): Homo sapiens


PROVIDER: E-MTAB-6742 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Similar Datasets

2024-07-08 | E-MTAB-11925 | biostudies-arrayexpress
2012-04-26 | GSE31129 | GEO
2015-05-22 | E-GEOD-68356 | biostudies-arrayexpress
2012-04-25 | E-GEOD-31129 | biostudies-arrayexpress
2014-01-01 | E-GEOD-46502 | biostudies-arrayexpress
2015-05-22 | E-GEOD-68355 | biostudies-arrayexpress
2014-01-01 | E-GEOD-43788 | biostudies-arrayexpress
2018-10-04 | GSE107966 | GEO
2015-12-17 | GSE69294 | GEO
2015-12-17 | GSE69295 | GEO